Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Duvoux

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Blood|March 10, 2001
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trialE Haddad, S Paczesny, V Leblond, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 31, 2017
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized TrialF Saliba, C Duvoux, J Gugenheim, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 30, 2013
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter studyF Saliba, P De Simone, F Nevens, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 14, 2012
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trialP De Simone, F Nevens, L De Carlis, et al.
Transplantation Proceedings|June 24, 1998
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantationD Samuel, H Bismuth, O Boillot, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT studyR Anty, G Favre, A Coilly, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Blood|March 10, 2001
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trialE Haddad, S Paczesny, V Leblond, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 31, 2017
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized TrialF Saliba, C Duvoux, J Gugenheim, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 30, 2013
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter studyF Saliba, P De Simone, F Nevens, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 14, 2012
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trialP De Simone, F Nevens, L De Carlis, et al.
Transplantation Proceedings|June 24, 1998
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantationD Samuel, H Bismuth, O Boillot, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT studyR Anty, G Favre, A Coilly, et al.
Pageof 7